GIM
DORM icon

Glenmede Investment Management’s Dorman Products DORM Stock Holding History

Glenmede Investment Management’s Portfolio DORM Stock Details DORM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$349K Sell
2,239
-136
-6% -$19.5K ﹤0.01% 1073
2025
Q2 		$291K Buy
+2,375
New +$289K ﹤0.01% 1114

Other funds holding DORM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Glenmede Investment Management's DORM Position: Q3 2025 in Review

Glenmede Investment Management reduced its Dorman Products (DORM) stake by 5.7% in Q3 2025, selling an estimated $19.5K and leaving 2,239 shares worth $349K. The position accounts for ﹤0.01% of the portfolio, ranked #1073.

Glenmede Investment Management first reported a position in DORM in Q2 2025 and has held it in 2 quarters since. 345 funds tracked by Wall St. Rank hold DORM as of Q3 2025.

  • Glenmede Investment Management held 2,239 shares of Dorman Products worth $349K as of Q3 2025.
  • Glenmede Investment Management sold 136 Dorman Products shares in Q3 2025, an estimated $19.5K.
  • Dorman Products made up ﹤0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #1073 holding.
  • Glenmede Investment Management first reported a position in Dorman Products in Q2 2025 and has held it in 2 quarters since.
  • 345 funds tracked by Wall St. Rank held Dorman Products as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.